H1N1 Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The H1N1 Vaccines market is segmented By Product Type (Inactivated Vaccine, Live Attenuated Vaccine), By Route of Administration and Geography.

H1N1 Vaccines Market Size

H1N1 Vaccines Market Analysis

The H1N1 Vaccines Market is expected to register a CAGR of 5.2% during the forecast period.

According to the World Health Organization (WHO), annually about 3 to 5 million cases of severe illness and about 2,90,000 to 6,50,000 respiratory deaths are due to seasonal influenza. In the case of industrialized countries, most of the deaths due to influenza occur among people above 65 years of age. Seasonal influenza illnesses range from mild to severe and even death.

Increasing incidences of epidemic H1N1 infection and declining immunity among the geriatric population and technological advancements in the vaccines are the key driving factors in the H1N1 vaccines market.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the H1N1 vaccines market due to increasing government initiatives for the prevention of H1N1 infection and improved research infrastructure in this region. According to the Centers for Disease Control (CDC), about 8 percent of the United States population gets sick from the flu. In addition, approximately 31.4 million people visit the doctor and 200,000 people end up in the hospital every flu season. Moreover, technological advancements in the vaccines field and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

H1N1 Vaccines Industry Overview

The H1N1 Vaccines Market is consolidated and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are MedImmune LLC (AstraZeneca PLC), Sanofi Pasteur AG, GlaxoSmithKline Plc, Abbott Laboratories, CSL Limited (Seqirus GmbH), Pfizer Inc, CPL Biologicals Pvt. Ltd, Mitsubishi Tanabe Pharma Corporation, Sinovac Biotech Ltd and Zydus Cadila.

H1N1 Vaccines Market Leaders

  1. AstraZeneca Plc

  2. Sanofi (Sanofi Pasteur AG)

  3. GlaxoSmithKline Plc

  4. Abbott Laboratories

  5. CSL Limited (Seqirus GmbH)

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

H1N1 Vaccines Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Epidemic H1N1 Infection and Declining Immunity Among people
    • 4.2.2 Technological Advancements in the Vaccines Field
  • 4.3 Market Restraints
    • 4.3.1 High costs of H1N1 Vaacines
    • 4.3.2 Lengthy Manufacturing Process of H1N1 Vaacines
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Inactivated Vaccine
    • 5.1.2 Live Attenuated Vaccine
  • 5.2 By Route of Administration
    • 5.2.1 Intradermal Vaccines
    • 5.2.2 Intramuscular Vaccines
    • 5.2.3 Intranasal Vaccines
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 MedImmune LLC (AstraZeneca PLC)
    • 6.1.2 Sanofi Pasteur AG
    • 6.1.3 GlaxoSmithKline Plc
    • 6.1.4 Abbott Laboratories
    • 6.1.5 CSL Limited (Seqirus GmbH)
    • 6.1.6 Pfizer Inc
    • 6.1.7 CPL Biologicals Pvt. Ltd
    • 6.1.8 Mitsubishi Tanabe Pharma Corporation
    • 6.1.9 Sinovac Biotech Ltd
    • 6.1.10 Zydus Cadila
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

H1N1 Vaccines Industry Segmentation

The H1N1 virus, commonly known as swine flu is an infectious disease in humans caused by the swine H1N1 virus, which is characterized by a persistent cough, cold, high fever, red watery eyes, body aches, headache, and general discomfort. H1N1 Vaccines Market is segmented By Product Type, By Route of Administration and Geography.

By Product Type Inactivated Vaccine
Live Attenuated Vaccine
By Route of Administration Intradermal Vaccines
Intramuscular Vaccines
Intranasal Vaccines
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
By Product Type
Inactivated Vaccine
Live Attenuated Vaccine
By Route of Administration
Intradermal Vaccines
Intramuscular Vaccines
Intranasal Vaccines
Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

H1N1 Vaccines Market Research FAQs

What is the current H1N1 Vaccines Market size?

The H1N1 Vaccines Market is projected to register a CAGR of 5.2% during the forecast period (2025-2030)

Who are the key players in H1N1 Vaccines Market?

AstraZeneca Plc, Sanofi (Sanofi Pasteur AG), GlaxoSmithKline Plc, Abbott Laboratories and CSL Limited (Seqirus GmbH) are the major companies operating in the H1N1 Vaccines Market.

Which is the fastest growing region in H1N1 Vaccines Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in H1N1 Vaccines Market?

In 2025, the North America accounts for the largest market share in H1N1 Vaccines Market.

What years does this H1N1 Vaccines Market cover?

The report covers the H1N1 Vaccines Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the H1N1 Vaccines Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Our Best Selling Reports

H1N1 Vaccines Industry Report

Statistics for the 2025 H1N1 Vaccines market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. H1N1 Vaccines analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

H1N1 Vaccines Report Snapshots

Access Report